SAT0408 Long-Term Safety and Tolerability of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of Three Phase 3, Randomized, Controlled Trials

2014 ◽  
Vol 73 (Suppl 2) ◽  
pp. 742.2-743 ◽  
Author(s):  
P.J. Mease ◽  
A. Kavanaugh ◽  
D. Gladman ◽  
A.O. Adebajo ◽  
J.J. Gomez-Reino ◽  
...  
Keyword(s):  
Psoriatic Arthritis ◽  
Randomized Controlled Trials ◽  
Safety Analysis ◽  
Controlled Trials ◽  
Phase 3 ◽  
Phosphodiesterase 4 ◽  
Randomized Controlled ◽  
Three Phase ◽  
Phosphodiesterase 4 Inhibitor

SAT0299 Apremilast: Pooled Safety Analysis of Three Phase 3, Randomized, Controlled Trials in patients with Psoriatic Arthritis

2013 ◽  
Vol 72 (Suppl 3) ◽  
pp. A685.1-A685 ◽  
Author(s):  
P. J. Mease ◽  
A. Kavanaugh ◽  
A. O. Adebajo ◽  
J. J. Gomez-Reino ◽  
J. Wollenhaupt ◽  
...  
Keyword(s):  
Psoriatic Arthritis ◽  
Randomized Controlled Trials ◽  
Safety Analysis ◽  
Controlled Trials ◽  
Phase 3 ◽  
Randomized Controlled ◽  
Three Phase
Sign in / Sign up

Export Citation Format

Share Document